ArticleLeukemia & lymphoma2023

Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma.

Christian Grommes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.